Skip to Main Content

Browse issues

Clinical Infectious Diseases Cover Image for Volume 67, Issue 6
Volume 67, Issue 6
15 September 2018
ISSN 1058-4838
EISSN 1537-6591

Volume 67, Issue 6, 15 September 2018

NEWS

Clinical Infectious Diseases, Volume 67, Issue 6, 15 September 2018, Pages i–ii, https://doi.org/10.1093/cid/ciy579

IN THE LITERATURE

Clinical Infectious Diseases, Volume 67, Issue 6, 15 September 2018, Pages iii–iv, https://doi.org/10.1093/cid/ciy629

IDSA GUIDELINE

J Michael Miller and others
Clinical Infectious Diseases, Volume 67, Issue 6, 15 September 2018, Pages 813–816, https://doi.org/10.1093/cid/ciy584

ARTICLES AND COMMENTARIES

Rupam Tripura and others
Clinical Infectious Diseases, Volume 67, Issue 6, 15 September 2018, Pages 817–826, https://doi.org/10.1093/cid/ciy196

In Cambodian villages, 3-month mass drug administration with high coverage using dihydroartemisinin-piperaquine was safe and was followed by the absence of clinical Plasmodium falciparum cases for at least 1 year, despite the presence of multidrug-resistant parasites.

Miriam Eddyani and others
Clinical Infectious Diseases, Volume 67, Issue 6, 15 September 2018, Pages 827–834, https://doi.org/10.1093/cid/ciy197

A broader clinical suspicion of Buruli ulcer should be recommended to improve accuracy of its clinical diagnosis. Taking into consideration diagnostic accuracy, time to results, cost-effectiveness, and clinical generalizability, a stepwise approach reserving polymerase chain reaction to microscopy-negative patients performed best.

Tjip S van der Werf
Clinical Infectious Diseases, Volume 67, Issue 6, 15 September 2018, Pages 835–836, https://doi.org/10.1093/cid/ciy203
Lona Mody and others
Clinical Infectious Diseases, Volume 67, Issue 6, 15 September 2018, Pages 837–844, https://doi.org/10.1093/cid/ciy194

We sampled 651 recently admitted nursing facility patients and collected clinical and microbiological data over 1629 visits. We found that more than 57% were colonized with 1 or more multidrug-resistant organisms on enrollment, and 56% were colonized at discharge from the facility.

Sharon Alroy-Preis and others
Clinical Infectious Diseases, Volume 67, Issue 6, 15 September 2018, Pages 845–853, https://doi.org/10.1093/cid/ciy193

An outbreak of hepatitis C virus at a hospital was associated with drug diversion by a healthcare worker. Healthcare facilities and public health must work together to create proactive, comprehensive approaches to prevent, detect, and respond to drug diversion events.

Elita Jauneikaite and others
Clinical Infectious Diseases, Volume 67, Issue 6, 15 September 2018, Pages 854–860, https://doi.org/10.1093/cid/ciy174

Genomic surveillance for 2 years revealed that 11 of 12 late-onset group B streptococcus (GBS) infections in one neonatal intensive care unit were linked to ≥1 other GBS case, suggesting that even isolated late-onset GBS cases represent probable nosocomial transmission.

Marco Cassone and others
Clinical Infectious Diseases, Volume 67, Issue 6, 15 September 2018, Pages 861–868, https://doi.org/10.1093/cid/ciy115

Surveillance for antimicrobial-resistant organisms in nursing facilities is critically important but challenging. We developed simple panels of environmental sites that can be used as a proxy for determining nursing facility patient methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus colonization.

Takako Inoue and others
Clinical Infectious Diseases, Volume 67, Issue 6, 15 September 2018, Pages 869–877, https://doi.org/10.1093/cid/ciy205

In hepatitis C virus infection, the progression of the clinical stage is associated with gut dysbiosis, even if patients are asymptomatic. Overgrowth of viridans streptococci can contribute to the production of ammonia in chronic hepatitis and liver cirrhosis.

Eric G Meissner
Clinical Infectious Diseases, Volume 67, Issue 6, 15 September 2018, Pages 878–880, https://doi.org/10.1093/cid/ciy208
Heidi M Soeters and others
Clinical Infectious Diseases, Volume 67, Issue 6, 15 September 2018, Pages 881–889, https://doi.org/10.1093/cid/ciy187

Invasive Haemophilus influenzae disease has increased, particularly due to nontypeable strains and serotype a. A considerable burden of invasive H. influenzae disease affects the oldest and youngest age groups, particularly American Indian and Alaska Native children.

Kelly J Gambino-Shirley and others
Clinical Infectious Diseases, Volume 67, Issue 6, 15 September 2018, Pages 890–896, https://doi.org/10.1093/cid/ciy195

This investigation linked a multistate outbreak of Salmonella Virchow infections to a raw powdered meal replacement product. It highlights the complex nature of food safety and potential risks with similar products not intended to be cooked by consumers before consuming.

Nobuo Saito and others
Clinical Infectious Diseases, Volume 67, Issue 6, 15 September 2018, Pages 897–904, https://doi.org/10.1093/cid/ciy202

Attenuated vaccine effectiveness was observed against both medically attended influenza A and B caused by repeated trivalent inactivated influenza vaccine (TIV) immunization. Significant dose-dependent association was found between the degree of attenuation and the number of prior TIV vaccinations.

Nenad Macesic and others
Clinical Infectious Diseases, Volume 67, Issue 6, 15 September 2018, Pages 905–912, https://doi.org/10.1093/cid/ciy199

In a prospective genomic surveillance study of liver transplant patients, we found that temporal dynamics differed between multidrug-resistant organisms with respect to onset of intestinal colonization, clearance, and infections. Whole-genome sequencing revealed an unexpected diversity of carbapenem-resistant Enterobacteriaceae.

Nicolas Argy and others
Clinical Infectious Diseases, Volume 67, Issue 6, 15 September 2018, Pages 913–919, https://doi.org/10.1093/cid/ciy154

Investigation of atovaquone prophylactic treatment failures during a Pneumocystis infection outbreak in heart transplant recipients revealed a cytochrome b mutation associated with a modification of the protein structure on the binding site of the atovaquone, according to in silico mutagenesis.

Joost M Costerus and others
Clinical Infectious Diseases, Volume 67, Issue 6, 15 September 2018, Pages 920–926, https://doi.org/10.1093/cid/ciy200

Lumbar puncture in bacterial meningitis is only very rarely complicated by cerebral herniation. The interrater reliability of the assessment of contraindications for lumbar puncture on cranial computed tomography is moderate.

Yoshikazu Mutoh and others
Clinical Infectious Diseases, Volume 67, Issue 6, 15 September 2018, Pages 927–933, https://doi.org/10.1093/cid/ciy176

Using change point analysis, this study showed that even after long-term successful antiretroviral therapy in human immunodeficiency–infected patients with suppressed viremia, the CD4 cell count, CD4 percentage, and CD4/CD8 ratio did not recover to levels seen in healthy individuals.

Erik Mogalian and others
Clinical Infectious Diseases, Volume 67, Issue 6, 15 September 2018, Pages 934–940, https://doi.org/10.1093/cid/ciy201

Sofosbuvir/velpatasvir (SOF/VEL) may be administered with atazanavir, cobicistat, darunavir, dolutegravir, efavirenz (EFV), elvitegravir, emtricitabine, lopinavir, raltegravir, rilpivirine, ritonavir, tenofovir alafenamide, or tenofovir disoproxil fumarate without dose adjustment. Use of SOF/VEL with EFV is not recommended.

Chukwuma Mbaeyi and others
Clinical Infectious Diseases, Volume 67, Issue 6, 15 September 2018, Pages 941–946, https://doi.org/10.1093/cid/ciy180

This article describes the contributions of Village Polio Volunteers, a community-based program, to strengthening acute flaccid paralysis surveillance activities in Somalia, in furtherance of global efforts to eradicate polio.

Jing Peng and others
Clinical Infectious Diseases, Volume 67, Issue 6, 15 September 2018, Pages 947–953, https://doi.org/10.1093/cid/ciy198

We directly compared the performances of 2 commonly used syphilis screening algorithms to determine the optimal serological syphilis screening algorithm. Moreover, we also analyzed the meaning of isolated reactive results, which exists in both algorithms and has raised much confusion in interpretation.

BRIEF REPORTS

Philip W Lam and others
Clinical Infectious Diseases, Volume 67, Issue 6, 15 September 2018, Pages 954–957, https://doi.org/10.1093/cid/ciy301
Catia Cillóniz and others
Clinical Infectious Diseases, Volume 67, Issue 6, 15 September 2018, Pages 958–961, https://doi.org/10.1093/cid/ciy314
Donn J Colby and others
Clinical Infectious Diseases, Volume 67, Issue 6, 15 September 2018, Pages 962–964, https://doi.org/10.1093/cid/ciy321

VIEWPOINTS

David P Serota and others
Clinical Infectious Diseases, Volume 67, Issue 6, 15 September 2018, Pages 965–970, https://doi.org/10.1093/cid/ciy297

In a cohort of young black men who have sex with men, we observed high human immunodeficiency virus incidence despite education and access to preexposure prophylaxis (PrEP). Although PrEP has efficacy in clinical trials, we identify barriers to real-world effectiveness.

INVITED ARTICLE

IMMUNOCOMPROMISED HOST

Hanine El Haddad and others
Clinical Infectious Diseases, Volume 67, Issue 6, 15 September 2018, Pages 971–977, https://doi.org/10.1093/cid/ciy331

With the dual threat of increasing antimicrobial resistance and decreasing numbers of novel antimicrobial agents, biomarkers such as procalcitonin and proadrenomedullin may have a role in guiding antimicrobial therapy and limiting excessive use of antimicrobials in immunocompromised patients with cancer.

PHOTO QUIZ

Sujata Sajjan and Reeti Khare
Clinical Infectious Diseases, Volume 67, Issue 6, 15 September 2018, Pages 978–979, https://doi.org/10.1093/cid/ciy093

CORRESPONDENCE

Keaton S Smetana and Aaron M Cook
Clinical Infectious Diseases, Volume 67, Issue 6, 15 September 2018, Pages 980–981, https://doi.org/10.1093/cid/ciy189
Wael F Elamin and others
Clinical Infectious Diseases, Volume 67, Issue 6, 15 September 2018, Pages 981–982, https://doi.org/10.1093/cid/ciy191
Anne M Lachiewicz and David van Duin
Clinical Infectious Diseases, Volume 67, Issue 6, 15 September 2018, Pages 982–983, https://doi.org/10.1093/cid/ciy192
Alexis Walker and others
Clinical Infectious Diseases, Volume 67, Issue 6, 15 September 2018, Pages 983–984, https://doi.org/10.1093/cid/ciy239
Samer S El-Kamary and others
Clinical Infectious Diseases, Volume 67, Issue 6, 15 September 2018, Page 984, https://doi.org/10.1093/cid/ciy240
Shevin T Jacob and Robert Colebunders
Clinical Infectious Diseases, Volume 67, Issue 6, 15 September 2018, Pages 984–985, https://doi.org/10.1093/cid/ciy247
Susan S Ellenberg and others
Clinical Infectious Diseases, Volume 67, Issue 6, 15 September 2018, Pages 985–986, https://doi.org/10.1093/cid/ciy250

ERRATA

Clinical Infectious Diseases, Volume 67, Issue 6, 15 September 2018, Page 987, https://doi.org/10.1093/cid/ciy333
Clinical Infectious Diseases, Volume 67, Issue 6, 15 September 2018, Page 987, https://doi.org/10.1093/cid/ciy334
Clinical Infectious Diseases, Volume 67, Issue 6, 15 September 2018, Page 987, https://doi.org/10.1093/cid/ciy402

BOOK REVIEW

David Griffith
Clinical Infectious Diseases, Volume 67, Issue 6, 15 September 2018, Pages 988–989, https://doi.org/10.1093/cid/ciy351

ELECTRONIC ARTICLE

J Michael Miller and others
Clinical Infectious Diseases, Volume 67, Issue 6, 15 September 2018, Pages e1–e94, https://doi.org/10.1093/cid/ciy381

COVER

Clinical Infectious Diseases, Volume 67, Issue 6, 15 September 2018, Page NP, https://doi.org/10.1093/cid/ciy688
Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close